Related Experiment Video
Updated: Jan 25, 2026

Chronic Thromboembolic Pulmonary Hypertension and Assessment of Right Ventricular Function in the Piglet
Published on: November 4, 2015
[Venous thromboembolism - update 2019]
11 Universitäts GefässCentrum - Universitätsklinikum Carl Gustav Carus Dresden.
Insights
New diagnostic tools simplify venous thromboembolism (VTE) exclusion. New oral anticoagulants (NOACs) offer safer, simpler treatment and prophylaxis, reducing bleeding risk and VTE recurrence.
Area of Science:
- Cardiology
- Hematology
- Internal Medicine
Background:
- Venous thromboembolism (VTE) diagnosis and management have evolved.
- New diagnostic algorithms and risk stratification tools are impacting clinical practice.
Purpose of the Study:
- To provide an update on venous thromboembolism management in 2019.
- To highlight the role of new diagnostic strategies and oral anticoagulants.
Main Methods:
- Review of current diagnostic algorithms for VTE exclusion.
- Application of risk scores for patient stratification.
- Evaluation of new oral anticoagulants (NOACs) in treatment and prophylaxis.
Main Results:
- Diagnostic certainty for VTE exclusion is improved, even for general practitioners.
- Risk scores aid in identifying high-risk patients for monitoring.
- Outpatient treatment for low-risk pulmonary embolism is increasingly feasible.
- NOACs simplify treatment, reduce major bleeding compared to vitamin K antagonists, and show promise for paraneoplastic VTEs.
- Prophylactic NOACs are expected to increase extended secondary prophylaxis, lowering recurrence risk.
Conclusions:
- Modern diagnostic approaches enhance VTE exclusion certainty.
- NOACs represent a significant advancement in VTE treatment and prophylaxis, offering improved safety and efficacy.
- Future research should further validate NOACs for specific VTE types, such as paraneoplastic VTEs.
Abstract:
Venous thromboembolism - update 2019 Abstract. Abstract:The implication of new diagnostic algorithms in our daily clinical routine has simplified the diagnostic certainty, particularly in the case of exclusion of venous thromboembolism (VTE), so that even the general practitioner can already rule out venous thromboembolism with sufficient certainty. The introduction of risk scores in patients with a confirmed diagnosis can help to identify those patients who are at particular risk so you can monitor them. On the other hand, outpatient treatment of patients with pulmonary embolism in the low-risk category increases significantly. With the introduction of the new oral anticoagulants (NOAC), the treatment of these patients has been significantly simplified, and the risk of major bleeding compared to the vitamin K antagonists has been significantly reduced. For patients with paraneoplastic VTEs, the NOACs will also be an option in the future, which must be validated in studies even more precisely. Due to the low risk of bleeding NOACs in prophylactic dosing, the proportion of patients undergoing extended secondary prophylaxis will continue to increase in the future, reducing the risk of VTE recurrence.
More Related Videos
06:05The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time
Published on: February 19, 2021
07:41Induction and Phenotyping of Acute Right Heart Failure in a Large Animal Model of Chronic Thromboembolic Pulmonary Hypertension
Published on: March 17, 2022
Related Concept Videos
SI Units: 2019 Redefinition
A standard set of units has been defined...
Venous Return
What is Venous Return?
Venous return refers to the rate at which blood flows back to the heart from the body's peripheral veins. It's an integral part of the circulatory system...
Venous Thrombosis I: Introduction
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies